Biological hepatic markers of inflammation and fibrosis following durable sustained virological response to direct acting antiviral agents in HIV/HCV co-infected patients: preliminary results from the cohort driven by the CoReVIH at the University-Hospital of Clermont-Ferrand, France

• Guillaume Laurichesse,
• Sandrine Casanova,
• Audrey Mirand,
• Violaine Corbin,
• Paule Letertre,
• Natacha Mrozek,
• Magali Vidal,
• Cécile Henquel,
• Henri Laurichesse,
• Christine Jacomet

Affiliations

Guillaume Laurichesse

Infectious Diseases Unit, Clermont-Ferrand, France

Sandrine Casanova

Infectious Diseases Unit, Clermont-Ferrand, France

Audrey Mirand

Laboratory of Virology, Clermont-Ferrand, France

Violaine Corbin

Infectious Diseases Unit, Clermont-Ferrand, France

Paule Letertre

Infectious Diseases Unit, Clermont-Ferrand, France

Natacha Mrozek

Infectious Diseases Unit, Clermont-Ferrand, France

Magali Vidal

Infectious Diseases Unit, Clermont-Ferrand, France

Cécile Henquel

Laboratory of Virology, Clermont-Ferrand, France

Henri Laurichesse

Infectious Diseases Unit, Clermont-Ferrand, France

Christine Jacomet

Infectious Diseases Unit, CoReVIH Auvergne, Clermont-Ferrand, France